![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
30
PharmaCompass offers a list of Loperamide Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Loperamide Hydrochloride manufacturer or Loperamide Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Loperamide Hydrochloride manufacturer or Loperamide Hydrochloride supplier.
PharmaCompass also assists you with knowing the Loperamide Hydrochloride API Price utilized in the formulation of products. Loperamide Hydrochloride API Price is not always fixed or binding as the Loperamide Hydrochloride Price is obtained through a variety of data sources. The Loperamide Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Loperamide/simeticone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loperamide/simeticone, including repackagers and relabelers. The FDA regulates Loperamide/simeticone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loperamide/simeticone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loperamide/simeticone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loperamide/simeticone supplier is an individual or a company that provides Loperamide/simeticone active pharmaceutical ingredient (API) or Loperamide/simeticone finished formulations upon request. The Loperamide/simeticone suppliers may include Loperamide/simeticone API manufacturers, exporters, distributors and traders.
click here to find a list of Loperamide/simeticone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Loperamide/simeticone DMF (Drug Master File) is a document detailing the whole manufacturing process of Loperamide/simeticone active pharmaceutical ingredient (API) in detail. Different forms of Loperamide/simeticone DMFs exist exist since differing nations have different regulations, such as Loperamide/simeticone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Loperamide/simeticone DMF submitted to regulatory agencies in the US is known as a USDMF. Loperamide/simeticone USDMF includes data on Loperamide/simeticone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Loperamide/simeticone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Loperamide/simeticone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Loperamide/simeticone Drug Master File in Japan (Loperamide/simeticone JDMF) empowers Loperamide/simeticone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Loperamide/simeticone JDMF during the approval evaluation for pharmaceutical products. At the time of Loperamide/simeticone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Loperamide/simeticone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Loperamide/simeticone Drug Master File in Korea (Loperamide/simeticone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Loperamide/simeticone. The MFDS reviews the Loperamide/simeticone KDMF as part of the drug registration process and uses the information provided in the Loperamide/simeticone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Loperamide/simeticone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Loperamide/simeticone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Loperamide/simeticone suppliers with KDMF on PharmaCompass.
A Loperamide/simeticone CEP of the European Pharmacopoeia monograph is often referred to as a Loperamide/simeticone Certificate of Suitability (COS). The purpose of a Loperamide/simeticone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Loperamide/simeticone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Loperamide/simeticone to their clients by showing that a Loperamide/simeticone CEP has been issued for it. The manufacturer submits a Loperamide/simeticone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Loperamide/simeticone CEP holder for the record. Additionally, the data presented in the Loperamide/simeticone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Loperamide/simeticone DMF.
A Loperamide/simeticone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Loperamide/simeticone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Loperamide/simeticone suppliers with CEP (COS) on PharmaCompass.
A Loperamide/simeticone written confirmation (Loperamide/simeticone WC) is an official document issued by a regulatory agency to a Loperamide/simeticone manufacturer, verifying that the manufacturing facility of a Loperamide/simeticone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Loperamide/simeticone APIs or Loperamide/simeticone finished pharmaceutical products to another nation, regulatory agencies frequently require a Loperamide/simeticone WC (written confirmation) as part of the regulatory process.
click here to find a list of Loperamide/simeticone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Loperamide/simeticone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Loperamide/simeticone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Loperamide/simeticone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Loperamide/simeticone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Loperamide/simeticone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Loperamide/simeticone suppliers with NDC on PharmaCompass.
Loperamide/simeticone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Loperamide/simeticone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loperamide/simeticone GMP manufacturer or Loperamide/simeticone GMP API supplier for your needs.
A Loperamide/simeticone CoA (Certificate of Analysis) is a formal document that attests to Loperamide/simeticone's compliance with Loperamide/simeticone specifications and serves as a tool for batch-level quality control.
Loperamide/simeticone CoA mostly includes findings from lab analyses of a specific batch. For each Loperamide/simeticone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Loperamide/simeticone may be tested according to a variety of international standards, such as European Pharmacopoeia (Loperamide/simeticone EP), Loperamide/simeticone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loperamide/simeticone USP).